| Name | H2B clustered histone 3 |
| Description | Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Nucleosomes consist of approximately 146 bp of DNA wrapped around a histone octamer composed of pairs of each of the four core histones (H2A, H2B, H3, and H4). The chromatin fiber is further compacted through the interaction of a linker histone, H1, with the DNA between the nucleosomes to form higher order chromatin structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H2B family. Transcripts from this gene lack polyA tails; instead, they contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6p22-p21.3. [provided by RefSeq, Aug 2015] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n H2BC3 is a member of the histone H2B family that encodes a core component of the nucleosome, thereby playing a central role in chromatin packaging and the regulation of gene expression. Emerging evidence from several studies shows that the precise incorporation and modification of H2B variants are essential for maintaining genomic stability, modulating cell‐cycle progression, and orchestrating proper developmental as well as stress response pathways. For example, epigenetic alterations—including changes in DNA methylation regulating expression levels of H2B family members—have been linked to aberrant proliferation and resistance to endocrine therapy in breast cancer, suggesting that tight control of H2B protein dosage is critical for cellular homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In parallel, upregulation of H2B transcripts has been associated with lung carcinogenesis, where an increased expression of these variants correlates with tumor progression and poor clinical outcome."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In neurodegenerative models such as Huntington’s disease, dysregulation of H2B transcripts appears to participate in altering transcriptional networks that influence apoptosis and early neurogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Furthermore, systems‐level analyses in developmental disorders like Turner syndrome have identified H2B genes among hub candidates, suggesting that misregulation of chromatin dynamics may impact tissue differentiation and organogenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Together, these findings underscore that H2BC3 and related H2B family members are not merely structural proteins but act as dynamic regulators of chromatin architecture. Their proper expression and post‐translational modification help to maintain the balance of gene transcription and cellular proliferation, whereas their dysregulation can contribute to disease pathogenesis. As such, H2BC3 represents a potential biomarker and therapeutic target in conditions ranging from cancer to neurodevelopmental disorders.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Shweta R Nayak, Emily Harrington, David Boone, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Horm Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12672-015-0230-5"}], "href": "https://doi.org/10.1007/s12672-015-0230-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26113056"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26113056"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zhuoying Zeng, Jingjing Lu, Desheng Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Poly(ADP-ribose) glycohydrolase silencing-mediated H2B expression inhibits benzo(a)pyrene-induced carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Environ Toxicol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/tox.23034"}], "href": "https://doi.org/10.1002/tox.23034"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33044785"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33044785"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Karolina Świtońska, Wojciech J Szlachcic, Luiza Handschuh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of Altered Developmental Pathways in Human Juvenile HD iPSC With 71Q and 109Q Using Transcriptome Profiling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Cell Neurosci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fncel.2018.00528"}], "href": "https://doi.org/10.3389/fncel.2018.00528"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30713489"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30713489"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Tiantian Cheng, Xiaoli Li, Jinhu Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Investigation of hub genes involved in Turner syndrome using biological informatics methods."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Medicine (Baltimore) (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MD.0000000000029069"}], "href": "https://doi.org/10.1097/MD.0000000000029069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35356930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35356930"}]}]}]}
|
| NCBI Gene ID | 3018 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
H2BC3 has 2,833 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 22 datasets.
Click the + buttons to view associations for H2BC3 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of H2BC3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of H2BC3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of H2BC3 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing H2BC3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with H2BC3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with H2BC3 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with H2BC3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding H2BC3 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving H2BC3 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing H2BC3 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with H2BC3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of H2BC3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving H2BC3 protein from the KEGG Pathways 2026 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of H2BC3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving H2BC3 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving H2BC3 protein from the Reactome Pathways 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of H2BC3 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of H2BC3 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of H2BC3 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of H2BC3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with H2BC3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving H2BC3 protein from the WikiPathways Pathways 2024 dataset. | |